0001493152-23-046580.txt : 20231229
0001493152-23-046580.hdr.sgml : 20231229
20231229161536
ACCESSION NUMBER: 0001493152-23-046580
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231227
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Jeff Lynn
CENTRAL INDEX KEY: 0001971112
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 231527852
MAIL ADDRESS:
STREET 1: C/O BEYOND AIR, INC.
STREET 2: 900 STEWART AVENUE, SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 900 STEWART AVENUE
STREET 2: SUITE 301
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4
1
ownership.xml
X0508
4
2023-12-27
0
0001641631
Beyond Air, Inc.
XAIR
0001971112
Myers Jeff Lynn
C/O BEYOND AIR, INC.
900 STEWART AVENUE, SUITE 301
GARDEN CITY
NY
11530
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-12-27
4
S
0
3423
2.214
D
46577
D
The sales reported on this Form 4 represent shares of common stock of Beyond Air, Inc. sold by the reporting person to cover tax withholding obligations in connection with the vesting of previously granted restricted stock units.
This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.15 to $2.34, inclusive. The reporting person undertakes to provide to Beyond Air, Inc., any security holder of Beyond Air, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
/s/ Adam T. Newman, as attorney-in-fact
2023-12-29